tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market

Bright Minds Biosciences (DRUG) Income Statement

Compare
250 Followers

Bright Minds Biosciences Income Statement

Last quarter (Q3 2025), Bright Minds Biosciences's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Bright Minds Biosciences's net income was C$-5.24M. See Bright Minds Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -73.36KC$ -72.45KC$ -6.04KC$ 0.00C$ 0.00
Operating Expenses
C$ 2.74MC$ 7.29MC$ 14.73MC$ 8.60MC$ 469.36K
Depreciation and Amortization
C$ 73.36KC$ 72.45KC$ 6.04KC$ 8.62MC$ 474.93K
EBITDA
C$ -2.72MC$ -7.28MC$ -14.73MC$ 0.00C$ 0.00
Operating Income
C$ -2.81MC$ -7.37MC$ -14.74MC$ -8.76MC$ -469.36K
Other Income/Expenses
C$ 11.88KC$ -5.56KC$ -232.93KC$ -27.64KC$ -5.45K
Pretax Income
C$ -2.80MC$ -7.37MC$ -14.96MC$ -8.65MC$ -480.38K
Net Income
C$ -2.80MC$ -7.37MC$ -15.19MC$ -8.52MC$ -485.94K
Per Share Metrics
Basic EPS
C$ -0.65C$ -1.98C$ -6.15C$ -4.74C$ -0.38
Diluted EPS
C$ -0.65C$ -1.98C$ -6.15C$ -4.74C$ -0.38
Weighted Average Shares Outstanding
4.31M 3.72M 2.47M 1.79M 1.28M
Weighted Average Shares Outstanding (Diluted)
4.31M 3.72M 2.47M 1.79M 1.28M
Currency in CAD

Bright Minds Biosciences Earnings and Revenue History